RELATIONSHIP BETWEEN ONE-STAGE AND CHROMOGENIC FVIII ASSAY DISCREPANCIES AND GENETIC ANALYSIS OF FVIII GENE IN PATIENTS WITH NON-SEVERE HAEMOPHILIA A

被引：0
|
作者：
Obregon, J. [1 ]
Calvo Villas, J. M. [1 ]
Marco Rico, A. [2 ]
Herrero Martin, S. [3 ]
Urena, L. E. [4 ]
Lopez Jaime, F. J. [5 ]
Diaz Jordan, B. [6 ]
Garcia Diaz, C. [7 ]
Jurado Herrera, S. [8 ]
Perez Gonzalez, N. F. [8 ]
Garcia Candel, F. [9 ]
Marco Vera, P.
Fernandez Bello, I.
Montano Brioso, A. [10 ]
机构：
[1] Hosp Univ Miguel Servet, Zaragoza, Spain
[2] Hosp Gen Univ Alicante Doctor Balmis, Alicante, Spain
[3] Hosp Univ Guadalajara, Guadalajara, Spain
[4] Hosp Univ Virgen Ias Nieves, Granada, Spain
[5] Hosp Univ Reg Malaga, Malaga, Spain
[6] Hosp Gen Valdepenas, Ciudad Real, Spain
[7] Hosp Univ Burgos, Burgos, Spain
[8] Hosp Univ Torrcardenas, Almeria, Spain
[9] Hosp Clin Univ Virgen Arrixaca, Murcia, Spain
[10] Univ Salamanca, Hosp Univ Reg Malaga, Malaga, Spain
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO007
引用
收藏
页码：26 / 27
页数：2
相关论文
共 37 条
  • [11] Genetic analysis of non-severe hemophilia A phenotype with A discrepancy between one-stage and chromogenic factor VIII activity assays
    Valikhani, Amir
    Mirakhorly, Mojgan
    Namvar, Ali
    Rastegarlari, Ghasem
    Toogeh, Gholamreza
    Shirayeh, Fatemeh Vossough
    Ahmadinejad, Minoo
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (05)
  • [12] The one-stage assay or chromogenic assay to monitor baseline factor VIII levels and desmopressin effect in non-severe haemophilia A: Superiority or non-inferiority?
    Schutte, Lisette M.
    Hodes, Luca S.
    van Moort, Iris
    Stoof, Sara C. M.
    Leebeek, Frank W. G.
    Cnossen, Marjon H.
    de Maat, Moniek P. M.
    Kruip, Marieke J. H. A.
    HAEMOPHILIA, 2020, 26 (05) : 916 - 922
  • [13] Anti-FVIII inhibitor levels measured by one-stage assay or chromogenic assay show significant discrepancies that might lead to inappropriate clinical decisions
    Gilles, J.
    Grailly, S.
    Peerlinck, K.
    Jacquemin, M.
    Saint-Remy, J.
    HAEMOPHILIA, 2010, 16 : 86 - 86
  • [14] Higher FVIII:C measured by chromogenic substrate assay than by one-stage assay is associated with silent hemophilic arthropathy
    Ogawa, Mika
    Suzuki, Nobuaki
    Takahashi, Nobunori
    Tamura, Shogo
    Suzuki, Atsuo
    Suzuki, Sachiko
    Hattori, Yuua
    Kakihara, Misaki
    Kanematsu, Takeshi
    Kojima, Toshihisa
    Katsumi, Akira
    Hayakawa, Fumihiko
    Kojima, Tetsuhito
    Ishiguro, Naoki
    Kiyoi, Hitoshi
    Matsushita, Tadashi
    THROMBOSIS RESEARCH, 2020, 188 : 103 - 105
  • [15] Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF®-treated patients
    Pouplard, C.
    Ternisien, C.
    Desconclois, C.
    Lasne, D.
    Aillaud, M. -F.
    Caron, C.
    HAEMOPHILIA, 2016, 22 (02) : E101 - E103
  • [16] Multi-centre Australia wide study comparing FVIII assay variation in haemophilia A patients receiving two different recombinant FVIII products using the one stage and chromogenic assays
    Khoo, T. L.
    Kershaw, G.
    Matthews, S.
    Clare, W.
    Bowyer, A.
    Kitchen, S.
    Dunkley, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 669 - 669
  • [17] The Relationship between Thrombin Generation Assay and FVIII Levels in Patients with Mild to Moderate Haemophilia (A)
    Luo, Pu-Lin
    Austin, Steven K.
    Parmar, Kiran
    Hart, Dan P.
    Laffan, Michael
    BLOOD, 2018, 132
  • [18] One-stage assay analysis demonstrates that gene therapy-derived factor VIII (FVIII) from dirloctocogene samoparvovec reduced clot times compared with endogenous FVIII at comparable FVIII levels
    Rizzo, C.
    Rojas, I. Y.
    Blanchard, E. L.
    Lupo, D.
    Chang, T.
    Coleman, J.
    Howard, V.
    Peed, L.
    Straub, R.
    Hanby, H.
    Alexander, J. M.
    Riling, C. R.
    HAEMOPHILIA, 2024, 30 : 63 - 63
  • [19] Factor VIII assessment using one-stage clot and chromogenic assay in trials investigating pharmacokinetics of different FVIII products
    Tiede, A.
    Ezban, M.
    Krogh-Meibom, T.
    Saugstrup, T.
    Moss, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 974 - 974
  • [20] Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays
    Stralfors, Annelie
    Mikovic, Danijela
    Schmidt, David
    Onelov, Liselotte
    Soutari, Nida Mahmoud Hourani
    Berndtson, Maria
    Chaireti, Roza
    Holmstrom, Margareta
    Antovic, Jovan P.
    Bruzelius, Maria
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (01) : 27 - 35
1234